After spending months in fundraising conversations for Blossend's seed round at $12M pre-money valuation, I have a clear picture of what VCs actually care about versus what founders think they care about. The gap between perception and reality is enormous.
What VCs actually care about, ranked. Number one: unit economics. Not revenue, not growth rate — unit economics. A company growing 50% month-over-month with -2:1 LTV/CAC is a ticking time bomb. A company growing 10% month-over-month with strong LTV/CAC is a printing press. Every sophisticated investor I spoke with asked about LTV/CAC within the first ten minutes. Our strong ratio was the single most compelling data point in the entire pitch.
Number two: retention. Retention is the most honest metric in SaaS because it cannot be gamed. You can inflate revenue with discounts, inflate users with bots, inflate growth with unsustainable spending. You cannot fake Strong annual retention — it means customers genuinely value the product and choose to keep paying. Multiple investors told me that they evaluate retention before looking at any other metric because high retention validates product-market fit more reliably than any other signal.
Number three: founder-problem authenticity. VCs have pattern-matched on a critical insight: founders who are personally connected to the problem they are solving are significantly more likely to persevere through the inevitable difficulties of startup building. My autoimmune crisis story — the personal experience that led to OpenMyPro — was not just color for the pitch deck. It was the primary reason several investors advanced to the next stage. They knew I would not quit when things got hard because the problem was personal.
Number four: capital efficiency. How much did you accomplish with how little? Blossend's breakeven on $65K total investment demonstrated execution discipline that most funded teams with millions cannot match. This metric gave investors confidence that additional capital would be deployed efficiently, not wasted on premature scaling.
What VCs care about less than founders think. Market size slides. Every startup claims a billion-dollar TAM. VCs have seen thousands of these slides and they all look the same. Show market size through traction, not through top-down analysis. Competitor analysis slides. VCs know your competitors better than you do — they have probably evaluated them. Instead of listing features in a comparison matrix, explain your structural advantages (moats) and why they compound over time. Revenue projections. Nobody believes five-year financial projections from a seed-stage startup. Show the assumptions behind the projections and explain why they are conservative.
The meta-lesson: fundraising is not about selling a dream. It is about demonstrating that you have already validated the critical assumptions that determine whether the dream can become reality. Unit economics, retention, founder authenticity, and capital efficiency are evidence of validation. Slide decks and projections are just presentation.